ATE121947T1 - Verbessertes meningokokkale polysaccharidkonjugatvakzin. - Google Patents

Verbessertes meningokokkale polysaccharidkonjugatvakzin.

Info

Publication number
ATE121947T1
ATE121947T1 AT91900142T AT91900142T ATE121947T1 AT E121947 T1 ATE121947 T1 AT E121947T1 AT 91900142 T AT91900142 T AT 91900142T AT 91900142 T AT91900142 T AT 91900142T AT E121947 T1 ATE121947 T1 AT E121947T1
Authority
AT
Austria
Prior art keywords
conjugate vaccine
polysaccharide conjugate
meningococcal polysaccharide
improved
improved meningococcal
Prior art date
Application number
AT91900142T
Other languages
English (en)
Inventor
Harold J Jennings
Francis Michon
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Application granted granted Critical
Publication of ATE121947T1 publication Critical patent/ATE121947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT91900142T 1989-12-14 1990-12-13 Verbessertes meningokokkale polysaccharidkonjugatvakzin. ATE121947T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44819589A 1989-12-14 1989-12-14

Publications (1)

Publication Number Publication Date
ATE121947T1 true ATE121947T1 (de) 1995-05-15

Family

ID=23779371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900142T ATE121947T1 (de) 1989-12-14 1990-12-13 Verbessertes meningokokkale polysaccharidkonjugatvakzin.

Country Status (30)

Country Link
US (3) US5576002A (de)
EP (1) EP0504202B1 (de)
JP (1) JP2637845B2 (de)
KR (1) KR0158436B1 (de)
CN (4) CN1049223C (de)
AR (1) AR243934A1 (de)
AT (1) ATE121947T1 (de)
AU (1) AU641715B2 (de)
BR (1) BR9007917A (de)
CA (1) CA2071811C (de)
CZ (1) CZ283530B6 (de)
DE (1) DE69019164T2 (de)
DK (1) DK0504202T3 (de)
ES (1) ES2071288T3 (de)
FI (2) FI104539B (de)
HR (1) HRP920872A2 (de)
HU (2) HU218146B (de)
IE (1) IE68414B1 (de)
IL (1) IL96676A (de)
IN (1) IN171747B (de)
NO (2) NO305275B1 (de)
NZ (1) NZ236471A (de)
PH (1) PH30305A (de)
PL (2) PL166035B1 (de)
RO (1) RO111416B1 (de)
RU (1) RU2105568C1 (de)
SI (1) SI20008B (de)
WO (1) WO1991008772A1 (de)
YU (1) YU24391A (de)
ZA (1) ZA9010065B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
RO111416B1 (ro) * 1989-12-14 1996-10-31 Ca Nat Research Council Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare
PT667787E (pt) * 1992-09-24 2001-10-31 Brigham & Womens Hospital Vacinas de conjugado de polissacarido-proteina de estreptococos do grupo b do tipo ii e tipo v
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
ATE400295T1 (de) * 1995-06-07 2008-07-15 Glaxosmithkline Biolog Sa Vakzine mit einem polysaccharide antigen- trägerprotein konjugat und freiem trägerprotein
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
DE69708318T3 (de) 1996-08-27 2006-11-16 Novartis Vaccines and Diagnostics, Inc., Emeryville Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
JP4150082B2 (ja) 1996-08-27 2008-09-17 カイロン コーポレイション 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
EP0994723A1 (de) 1997-06-24 2000-04-26 Chiron Corporation Verfahren um erwachsenen mit anti-meningokokken impfstoffzusammensetzungen zu immunizieren
AU9120898A (en) 1997-08-27 1999-03-16 Chiron Corporation Molecular mimetics of meningococcal b epitopes
HUP0100623A3 (en) 1997-12-23 2003-11-28 Baxter Healthcare S A Wallisel Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
EP1109576B1 (de) * 1998-08-19 2009-10-21 Baxter Healthcare SA Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
US6436653B1 (en) 1998-12-15 2002-08-20 Exiqon A/S Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
ATE455793T1 (de) 2001-04-17 2010-02-15 Novartis Vaccines & Diagnostic Monoklonale antikörper gegen molekulare mimetika von meningokokken-b-epitopen
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MXPA04009339A (es) * 2002-03-26 2005-01-25 Chiron Srl Sacaridos modificados que tienen estabilidad mejorada en agua.
WO2004089407A2 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
WO2005016949A2 (en) 2003-08-12 2005-02-24 Lipoxen Technologies Limited Sialic acid derivatives
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
WO2006002402A2 (en) 2004-06-23 2006-01-05 Children's Hospital & Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
MX2007016403A (es) 2005-06-27 2008-03-07 Glaxosmithkline Biolog Sa Composicion inmunogenica.
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
GB0611914D0 (en) 2006-06-15 2006-07-26 Teti Giuseppe Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
EP1872791A1 (de) 2006-06-30 2008-01-02 Institut Pasteur Verwendung von Polysacchariden bakteriellen Ursprungs zur Hemmung der Bildung von Biofilmen
US20100189740A1 (en) * 2007-06-20 2010-07-29 Francis Michon Modified polysaccharides for conjugate vaccines
US8815253B2 (en) 2007-12-07 2014-08-26 Novartis Ag Compositions for inducing immune responses
WO2010083477A2 (en) 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
EP2752403A1 (de) * 2013-01-08 2014-07-09 Sika Technology AG Amin für emissionsarme Epoxidharz-Produkte
CN108135167B (zh) 2015-08-19 2021-07-09 哈佛学院院长及董事 脂化psa组合物和方法
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
SG11201906519RA (en) * 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
RO111416B1 (ro) * 1989-12-14 1996-10-31 Ca Nat Research Council Polizaharide modificate de neisseria meningitidis si e coli, combinatii antigenice si metoda de imunizare

Also Published As

Publication number Publication date
CN1100428A (zh) 1995-03-22
FI19991917A (fi) 1999-09-09
NO973311D0 (no) 1997-07-17
SI20008B (en) 2001-02-28
NO922316L (no) 1992-08-14
CN1036522C (zh) 1997-11-26
EP0504202A1 (de) 1992-09-23
CZ283530B6 (cs) 1998-04-15
RO111416B1 (ro) 1996-10-31
PL166035B1 (pl) 1995-03-31
IL96676A (en) 1996-09-12
IL96676A0 (en) 1991-09-16
FI104539B (fi) 2000-02-29
SI20008A (sl) 2000-02-29
IE904513A1 (en) 1991-06-19
CN1072506C (zh) 2001-10-10
AU641715B2 (en) 1993-09-30
ES2071288T3 (es) 1995-06-16
DE69019164D1 (de) 1995-06-08
AR243934A1 (es) 1993-09-30
WO1991008772A1 (en) 1991-06-27
EP0504202B1 (de) 1995-05-03
CZ628490A3 (en) 1997-12-17
PL166659B1 (pl) 1995-06-30
JP2637845B2 (ja) 1997-08-06
HU9201966D0 (en) 1992-10-28
US5902586A (en) 1999-05-11
NO307835B1 (no) 2000-06-05
NO973311L (no) 1992-08-14
NO922316D0 (no) 1992-06-12
RU2105568C1 (ru) 1998-02-27
DK0504202T3 (da) 1995-10-02
CN1096516A (zh) 1994-12-21
CN1055541A (zh) 1991-10-23
BR9007917A (pt) 1992-10-20
CN1100656A (zh) 1995-03-29
NZ236471A (en) 1992-10-28
CN1036504C (zh) 1997-11-26
HUT64480A (en) 1994-01-28
YU24391A (sh) 1995-12-04
HRP920872A2 (en) 1997-06-30
PL288271A1 (en) 1991-12-16
CA2071811C (en) 2003-11-04
FI922737A0 (fi) 1992-06-12
CN1049223C (zh) 2000-02-09
PH30305A (en) 1997-02-20
IN171747B (de) 1992-12-26
US5576002A (en) 1996-11-19
KR0158436B1 (ko) 1998-12-01
CA2071811A1 (en) 1991-06-15
ZA9010065B (en) 1992-02-26
DE69019164T2 (de) 1995-09-07
AU6898791A (en) 1991-07-18
JPH05505392A (ja) 1993-08-12
HU218146B (hu) 2000-06-28
IE68414B1 (en) 1996-06-12
NO305275B1 (no) 1999-05-03
US5683699A (en) 1997-11-04

Similar Documents

Publication Publication Date Title
ATE121947T1 (de) Verbessertes meningokokkale polysaccharidkonjugatvakzin.
IT9048521A0 (it) Dispositivo di somministrazione.
DE68911131D1 (de) Cellulosezubereitung.
DE69014358D1 (de) Kosmetisches Präparat.
DE69002302D1 (de) Synchronisiereinrichtung.
DE69007311D1 (de) Konjugate.
DE68906762D1 (de) Prostaglandin-polysaccharid-konjugat.
DE69005882D1 (de) Entfärbungsmittel.
FI915769A0 (fi) Permanent taetning foer paofyllningsbehaollare.
NL990018I1 (nl) Vaccin tegen Pasteurella.
NO902166D0 (no) Justerbart forbindelsesapparat.
NO903169D0 (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
FI915702A0 (fi) Peptider och daerav erhaollna antikroppar foer diagnos av vaccination emot htlv-1 infektion.
NO875038D0 (no) Konjugert vaksine.
FR2715304B1 (fr) Vaccin anti-allergique.
DE69012976D1 (de) Bodenbearbeitungsmaschine.
IT1236969B (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone.
NO900442L (no) Vaksineblanding.
DE69020848D1 (de) Impfstoff gegen IBV.
DE69002865D1 (de) Orale Zubereitung.
DE59003439D1 (de) Grubber.
DE68918189D1 (de) Neisseria-Vakzine.
DE68910125D1 (de) Oral-Präparate.
DE69001062T3 (de) Kleiderbügel.
NO901959L (no) Malaria-vaksine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee